DOACs in the Management of New-Onset Venous Thromboembolism and Nonvalvular Atrial Fibrillation
In this podcast, Isaac Nichols, PharmD, speaks about the appropriateness of direct oral\xa0anticoagulation\xa0prescribing for\xa0new-onset\xa0venous thromboembolism and\xa0nonvalvular\xa0atrial fibrillation, specifically the Xa inhibitors, rivaroxaban\xa0and apixaban. He presented on this topic at ASHP Midyear 2021.